Close

Form 4 NEOGENOMICS INC For: Apr 22 Filed by: Weiss Lawrence Martin

April 26, 2021 5:49 PM EDT
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Weiss Lawrence Martin

(Last) (First) (Middle)
12701 COMMONWEALTH DRIVE SUITE 9

(Street)
FORT MYERS FL 33913

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
3. Date of Earliest Transaction (Month/Day/Year)
04/22/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/22/2021   M   6,667 A $ 9.22 112,464 D  
Common Stock 04/22/2021   M   9,005 A $ 19.6 121,469 D  
Common Stock 04/22/2021   M   9,378 A $ 28.33 130,847 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $ 9.22 04/22/2021   M     6,667   (1) 04/19/2023 Common Stock 6,667.00 $ 0 0 D  
Stock Option (Right to Buy) $ 19.60 04/22/2021   M     9,005   (2) 03/01/2024 Common Stock 9,005.00 $ 0 18,012 D  
Stock Option (Right to Buy) $ 28.33 04/22/2021   M     9,378   (3) 03/02/2027 Common Stock 9,378.00 $ 0 28,136 D  
Stock Option (Right to Buy) $ 13.87               (4) 12/12/2023 Common Stock 8,334.00   8,334 D  
Stock Option (Right to Buy) $ 53.17               (5) 03/02/2028 Common Stock 29,895.00   29,895 D  
Explanation of Responses:
1. On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
2. On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
3. On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
4. On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
5. On March 2, 2021, Dr. Weiss was granted 29,895 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/ Lawrence M. Weiss 04/26/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY

Be it acknowledged that I, Lawrence Weiss with a mailing address of 31 Columbia, Aliso Viejo, California 92656, the "Principal," do hereby grant a limited and specific power of attorney to Jessica King and Denise E. Pedulla of 12701 Commonwealth Drive, Suite 9, Fort Myers, Florida 33913, each as my "Attorney-in-Fact."

Said Attorneys-in-Fact shall have full power and authority to undertake and perform only the following acts on my behalf:

Liaising with government or other entities as necessary for the purpose of filing documents with the Securities and Exchange Commission on my behalf.

The authority herein shall include such incidental acts as are reasonably required to carry out and perform the specific authorities granted herein. My Attorney-in-Fact agrees to accept this appointment subject to its terms and agrees to act and perform in said fiduciary capacity consistent with my best interest, as my Attorney-in-Fact in her discretion, deems advisable.

The Attorney-in-Fact shall be able to have the authority herein beginning December 11, 2018 and end when the act has been completed. Immediately afterwards this form shall become void. In addition, this Power of Attorney shall immediately be voided upon a revocation form being authorized by the Principal.

This Power of Attorney is governed by the laws of the State of California and shall be signed by the presence of two (2) witnesses.

Principal

/s/ Lawrence Weiss


ACCEPTANCE OF APPOINTMENT
I, Jessica King, the Attorney-in-Fact, hereby accept appointment as Attorney-in-Fact in accordance with the foregoing instrument.
Attorney-in-Fact

/s/ Jessica King

I, Denise E. Pedulla, the Attorney-in-Fact, hereby accept appointment as Attorney-in-Fact in accordance with the foregoing instrument.
Attorney-in-Fact

/s/ Denise E. Pedulla

Affirmation by Witness 1
I, Liane Iguchi, witnessed the execution of this Power of Attorney by Lawrence Weiss and I affirm that he appeared to me to be of sound mind, was not under duress, and affirmed to me that he was aware of the nature of this Power of Attorney and signed it freely and voluntarily.

Witness 1 Signature /s/Liane Iguchi
Print Name: Liane Iguchi
Date: 12/11/2018

Affirmation by Witness 2
I, Shereen Anderson, witnessed the execution of this Power of Attorney by Lawrence Weiss and I affirm that he appeared to me to be of sound mind, was not under duress, and affirmed to me that he was aware of the nature of this Power of Attorney and signed it freely and voluntarily.

Witness 2 Signature /s/ Shereen Anderson
Print Name: Shereen Anderson
Date: 12/11/2018


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings